Internal Medicine · San Diego, CA
NPI
1881782647
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4537 College Avenue
San Diego, CA, 92115
Phone (619) 265-0504
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
2,748 services
Medicare patients, 2024
252
Average age 68
Drug cost, 2024
$669K
8,571 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neelakantan Ramineni was code 99232 (hospital e&m - subsequent), 1,341 times for 50 patients. In total Neelakantan Ramineni billed 2,748 services in 10 codes, and Medicare paid $186K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,341 | 50 | $58.10 | $78K |
| 99308 SNF E&M | Facility | 621 | 142 | $56.25 | $35K |
| 99309 SNF E&M | Facility | 435 | 109 | $75.29 | $33K |
| 99223 Hospital E&M - Initial | Facility | 142 | 102 | $127.48 | $18K |
| 99306 SNF E&M | Facility | 90 | 74 | $131.42 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 81 | 56 | $87.42 | $7,081 |
| 99239 Hospital Discharge Management | Facility | 22 | 18 | $85.58 | $1,883 |
By year: 2022 $221K for 3,012 services; 2023 $217K for 2,844 services; 2024 $186K for 2,748 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neelakantan Ramineni prescribed most often to Medicare patients was Atorvastatin Calcium, with 445 prescriptions and refills. In total Neelakantan Ramineni wrote 8,571 Medicare prescriptions that cost $669K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 445 | 656 | 77 | $6,361 |
| Levothyroxine Sodium Generic | 367 | 436 | 45 | $4,574 |
| Eliquis Apixaban | 366 | 368 | 32 | $107K |
| Famotidine Generic | 312 | 375 | 54 | $3,532 |
| Amlodipine Besylate Generic | 282 | 384 | 58 | $2,441 |
| Gabapentin Generic | 247 | 295 | 44 | $4,933 |
| Lisinopril Generic | 238 | 285 | 30 | $2,046 |
| Pantoprazole Sodium Generic | 228 | 295 | 43 | $5,516 |
| Metformin Hcl Generic | 226 | 345 | 36 | $2,341 |
| Tamsulosin Hcl Generic | 200 | 262 | 33 | $3,146 |
| Losartan Potassium Generic | 171 | 265 | 36 | $2,159 |
| Carvedilol Generic | 162 | 194 | 27 | $1,641 |
| Metoprolol Tartrate Generic | 158 | 196 | 25 | $1,348 |
| Olanzapine Generic | 156 | 162 | 20 | $3,420 |
| Memantine Hcl Generic | 151 | 153 | 18 | $6,320 |
Brand drugs: 1,349 claims; generic drugs: 7,183 claims; opioid claims: 60.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Neelakantan Ramineni were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.